Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.52 USD | -4.54% | +10.39% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 245M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -94M | EV / Sales 2024 * | - |
Net cash position 2024 * | 30.75M | Net cash position 2025 * | 36.28M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.29
x | P/E ratio 2025 * |
-2.96
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.54% |
1 day | -4.54% | ||
1 week | +10.39% | ||
Current month | +6.26% | ||
1 month | +5.09% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 10.52 | -4.54% | 123,758 |
24-05-22 | 11.02 | +0.27% | 61,932 |
24-05-21 | 10.99 | +3.48% | 87,312 |
24-05-20 | 10.62 | +9.82% | 219,419 |
24-05-17 | 9.67 | -2.91% | 92,480 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 245M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- BOLD Stock